FDA recall record

CJ Distribution (Oakland) CJ Extra Fancy Long Grain Enriched Rice recall — FDA F-0747-2016

FDA inspection found rodent urine stains on pallets of long grain rice in 80 lb. bags.

Class IIclassification
F-0747-2016official record ID
Mar 23, 2016report date

Recall record at a glance

Official recordF-0747-2016
CategoryFood Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmCJ Distribution (Oakland) Inc.
Report dateMar 23, 2016
Recall initiation dateDec 29, 2015
Quantity15 x 80 lb. bags (7 bags already returned)
LocationOakland, CA, United States

Official product description

CJ Extra Fancy Long Grain Enriched Rice. NET WT. 80 lbs (36.20 kg); nylon bag; Product of USA. Item number RG80

Why the product was recalled

FDA inspection found rodent urine stains on pallets of long grain rice in 80 lb. bags.

Distribution information

Northern CA Bay area only.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Telephone.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.